MAOA and breast carcinoma: Recently, Alkhawaldeh and Bardaweel tested several clorgyline-based MAO-A inhibitors and showed that they promoted apoptosis and suppressed the proliferation, invasiveness, and colony-forming abilities of a luminal A and TNBC-type breast cancer cell line, respectively.